CMG
Chipotle Mexican Grill, Inc.
CMG has the edge over TSLA overall, supported by stronger valuation and stronger modeled upside.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
CMG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
CMG's revenue, profitability, cash flow and balance sheet are all currently healthy.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
CMG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 28x | $35.17 | — |
| Current | 33x | $35.17 | — |
| Cheap | 37x | $39.28 | +12% |
| Fair | 56x | $59.81 | +70% |
| Expensive | 91x | $97.34 | +177% |
Historical ranges are pointers, not guarantees.
CMG has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
CMG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CMG has the edge over TSLA on the outlook, with more favorable profitability expectations.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
CMG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | +19% |
| Q3 2026 | $1.07 | -5.3% |
| Q2 2026 | $1.09 | -2.7% |
| Q1 2026 | $1.09 | -3.5% |
| Q4 2025 | $1.14 | +2.7% |
| Q3 2025 | $1.13 | +5.6% |
| Q2 2025 | $1.12 | +9.8% |
| Q1 2025 | $1.13 | +20% |
| Q4 2024 | $1.11 | +25% |
CMG has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
CMG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +9.6% |
| Q2 2026 | $3.3B | +9.3% |
| Q1 2026 | $3.1B | +7.4% |
| Q4 2025 | $3B | +4.9% |
| Q3 2025 | $3B | +7.5% |
| Q2 2025 | $3.1B | +3% |
| Q1 2025 | $2.9B | +6.4% |
| Q4 2024 | $2.8B | +13% |
CMG has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -2.2 points |
| Q2 2026 | 16% | -2.6 points |
| Q1 2026 | 13% | -3.8 points |
| Q4 2025 | 14% | -0.5 points |
| Q3 2025 | 16% | -1.1 points |
| Q2 2025 | 18% | -1.5 points |
| Q1 2025 | 17% | +0.3 points |
| Q4 2024 | 15% | +0.2 points |
CMG has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
CMG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $347.1M | -15% |
| Q2 2026 | $463.4M | +16% |
| Q1 2026 | $471M | +14% |
| Q4 2025 | $228.4M | -35% |
| Q3 2025 | $406.2M | +36% |
| Q2 2025 | $400.7M | -5.1% |
| Q1 2025 | $412.3M | -5.6% |
| Q4 2024 | $353.9M | +278% |
CMG has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
CMG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -11.4M shares |
| 1 year | -5.4% | -71.8M shares |
| 3 years | -8.4% | -116M shares |
| 5 years | -11% | -156M shares |
| Available history | -10% | -147M shares |
CMG has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $110M |
| Q2 2026 | $653.9M |
| Q1 2026 | $701M |
| Q4 2025 | $741.8M |
| Q3 2025 | $686.7M |
| Q2 2025 | $443.3M |
| Q1 2025 | $553.8M |
| Q4 2024 | $339M |
CMG spent $2.2B buying back its own shares over the past year, up 9.1% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
CMG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
CMG has more cash than debt.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over CMG on leverage, with a lower net debt burden relative to earnings.
CMG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 56.0 | Neutral |
CMG's weekly RSI is 53 (neutral) and its Stochastic is 56 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
CMG PE vs Consumer Cyclical Sector
| Metric | CMG | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 18x | 82% above |
| PE % | 11 | 47 | 36 pts below |
CMG has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
CMG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.8 | 11% above |
| 20 week MA | $33.8 | 4.1% above |
| 50 week MA | $34.6 | 1.7% above |
| 100 week MA | $41.3 | 15% below |
| 200 week MA | $44.6 | 21% below |
CMG has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 21% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over CMG on trend strength, trading above more of its moving averages.
CMG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $28.3 | +69% |
| 2021 | $28.3 | $35.0 | +24% |
| 2022 | $35.0 | $28.3 | -19% |
| 2023 | $28.3 | $45.7 | +62% |
| 2024 | $45.7 | $60.8 | +33% |
| 2025 | $60.8 | $37.8 | -38% |
| 2026 YTD | $37.8 | $35.2 | -7% |
CMG has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.